Difference between revisions of "Eric Crombez"
From QueerBio.com
| Line 1: | Line 1: | ||
| − | [[File: | + | [[File:ecrombez.jpg|200px|thumb|left|ERi Crombez]] |
==Country== | ==Country== | ||
| Line 18: | Line 18: | ||
==See Also== | ==See Also== | ||
| − | * [[ | + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] |
==Further Reading/Research== | ==Further Reading/Research== | ||
Latest revision as of 00:58, 29 August 2024
Country
United States
Birth - Death
Occupation
Business, Medicine
Description
Chief Medical Officer and Executive Vice President at Ultragenyx since 2023 responsible for strategic leadership of the clinical development and translational research programs, and oversees global development functions including Clinical Development, Clinical Operations, BioMetrics, Endpoint Development and Strategy, Regulatory Affairs and Drug Safety/Pharmacovigilance.. Member of the Board of Directors of Abeona Therapeutics since 2024. Former Chief Medical Officer at Dimension Therapeutics. Was assistant professor, Department of Pediatrics, Division of Medical Genetics at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).